Pillstats
Rx only · Injection, Powder, Lyophilized, For Solution · Intravenous

Azithromycin

Azithromycin Monohydrate

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US2 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCJ01FA10
RxCUI (US)18631
US makers2 labelers
Packages2
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.5K3.1K4.6K6.2K2025 Q12025 Q22025 Q32025 Q42026 Q1
3.6K
Rx · 2026 Q1
3.8K
Units dispensed
-30%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown1SUPPLYING
Eugia US LLCunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Apr 13, 2022
    RECALLRecall (Class II): Azithromycin for Injection USP Vial, 500 mg per vial, Rx only, Manufacturer: Auromedics Pharma LLC, NDC 55150-174-10

    cGMP deviations: Temperature abuse — Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office — USA nationwide.